Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice

Bristol-Myers Squibb · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
inflammatory-bowel-diseaseulcerative-colitis
colitis, ulcerative, ulcerative colitis, ozanimod, rpc-1063, zeposia®, inflammatory bowel disease, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 967503
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.